Skip to main content

Table 1 Means (± s.d) of the haematological variables for each blood component obtained with every anticoagulant

From: Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel

Variable

Anticoagulant

 

Sodium citrate (SC)

ACD-A

ACD-B

 

Whole blood

P-PRP

PPP

Whole blood

P-PRP

PPP

Whole blood

P-PRP

PPP

PLT (103/μL)

143.8 (19.4)a,b

390.6 (57.6)c

111.0 (22.6)

137.0 (21.3)a

399.1 (62.8)c

112.6 (23.7)

137.1 (25.4)a

398.5 (48.0)c

111.2 (18.5)

MPV (fL)

3.8 (0.4)

4.1 (0.6)b

3.6 (0.3)

3.8 (0.4)

4.2 (0.6)b

3.7 (0.4)

3.8 (0.4)d

4.2 (0.5)b

3.7 (0.4)

PDW (%)

16.5 (0.5)c

16.8 (0.5)c

17.8 (0.5)

16.3 (0.5)c

16.5 (0.6)c

17.6 (0.7)

16.1 (0.6)c

16.7 (0.6)c

17.8 (0.7)

WBC (103/μL)*

8.4 (1.7)c,d

9.5 (3.0)c

0.1 (0.0)

7.9 (2.0)c,d

9.8 (5.0)c

0.1 (0.0)

8.3 (2.3)e

10.6 (4.0)c

0.1 (0.0)

  1. ACD: acid citrate dextrose (solution-A,-B); P-PRP: pure platelet-rich plasma; PPP: platelet-poor plasma; PLT, platelets; MPV: mean platelet volume; PDW: platelet distribution width; WBC: white blood cells. Lower-case letters represent significant differences between blood components for every independent anticoagulant. Blood components significantly different with a: P-PRP (P <0.001); b: PPP (P <0.05); c: PPP (P <0.001); d: P-PRP (P <0.05); and e: P-PRP PPP (P <0.001); *Data are presented as medians (interquartile range (IR).